Publication | Open Access
Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
683
Citations
31
References
2008
Year
Weekly paclitaxel at the dose schedule used in the current study was well tolerated and demonstrated clinical benefit.
| Year | Citations | |
|---|---|---|
Page 1
Page 1